Page tree

Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

Overview of Current Notices

For additional Relevant links with regards to Content Development Information please click here Content Development Information

Improvement to the Release file naming convention for the Asssociation Reference file

In order to improve the description of this file, we will be updating the file naming convention from:

'der2_cRefset_AssociationReferenceSnapshot_INT_*.txt'

to:

'der2_cRefset_AssociationSnapshot_INT_*.txt'

....as of the January 2018 International Edition

TBC (ongoing)
ItemsProposed improvement

Planned Release date

(*this is provisional only and is subject to change)

1LOINC timeline changes - please refer to Roadmap link here LOINCJuly 2018 and potentially other future releases.
2

Revision of IS A relationships for anaotmy anatomy concepts 

The new anatomy concept model has implemented the new Description Logic features, e.g. reflective and transitive property, general concept axioms, for consistent logical modeling. However, the new model cannot be implemented in production because these DL features currently are not available in production. The implementation of them will depend on the enhanced logic profile for SNOMED CT which is under development by the Modeling AG. Yet, the inferred IS A relationship from the OWL anatomy ontology can be reviewed and implemented in the production. This will utilise the outcomes of the new anatomy model as well as evaluate the design of the new model. In particular, it is important to review the changes of IS-A relationships in anatomy for quality assurance and minimise impact to other hierarchies, such as disorders, procedures, observables, situations etc.

The first subject area is concepts under for revision is the sub-hierarchy of skin structure. Majority changes are completed The majority changes have been made in the January 2018 release. The rest will be completed in July 2018 releaseand following releases.

The subject area for revision of IS A revision in July 2018 relationships will be determined and updated in the following confluence page.

July 2018 International Edition
2

Improvement to the Release package naming convention

In order to ensure that the status of each package is correctly identified, we will be capitalising the third element of the naming convention. For example therefore, instead of the January 2018 International Edition release package being called:

SnomedCT_InternationalRF2_Production_20180131T120000Z.zip

It will instead be called:

SnomedCT_InternationalRF2_PRODUCTION_20180131T120000Z.zip

Alpha/Beta releases will be called:

SnomedCT_InternationalRF2_ALPHA_20180131T120000Z.zip

SnomedCT_InternationalRF2_BETA_20180131T120000Z.zip

This should have no impact on most users, this is provided for visibility of anyone who's upload routine might be case-sensitive.

January 2018 International Edition
3
3

Summary of Drugs changes

New hierarchies 766940004 | Role (role) and subhierarchy 766941000 | Therapeutic role (role) created with additional subtypes to be added in future releases

New semantic tags (role)

Attribute types New attributes created:

  • 766953001 |Count of active ingredient (attribute)|
  • 766954007 |Count of base and modification pair (attribute)|
  • 766952006 |Count of base of active ingredient (attribute)|
  • 763032000 |Has unit of presentation (attribute)|
  • 766939001 |Plays role (attribute)|

Grouper concepts representing disposition, intended site, and/or structure Grouper concepts representing disposition, intended site, and/or structure sufficiently defined by modeling to proximal primitive concept, adding defining attributes, and updating descriptions per editorial guidelines (n≈550).

New high level grouper concepts created as an incremental improvement with additional subtypes to be added in future releases:

  • 766779001 |Medicinal product categorized by disposition (product)|
  • 763760008 |Medicinal product categorized by structure (product)|
  • 767102007 |Medicinal product categorized by chemical element (product)|

Product role concepts Concepts representing product role relocated as stated descendants of 763087004 | Medicinal product categorized by role (product) with definition status = primitive and attributes inactivated (n≈ 400)

For further details see Briefing Note Use of Additional Axiom Functionality and Remodeling Product Roles

Medicinal product (MP) concepts - MP-containing concepts sufficiently defined by modeling to proximal primitive concept, adding defining attributes, and updating descriptions per editorial guidelines (n≈ 3750). Includes the following attributes:

  • Has active ingredient (n≈4650)

Medicinal product form (MPF) concepts - MPF-containing concepts sufficiently defined by modeling to proximal primitive concept, adding defining attributes, and updating descriptions per editorial guidelines (n≈2100). Includes the following attributes:

  • Has active ingredient (n≈2400)
  • Has manufactured dose form (n≈2150)

Clinical drug (CD) concepts - CD-containing precisely concepts sufficiently defined by modeling to proximal primitive concept, adding defining attributes, and updating descriptions per editorial guidelines (n≈ 4850). Includes the following attributes:

  • Count of base of active ingredient (n≈4850)
  • Has basis of strength substance (n≈5600)
  • Has concentration strength denominator unit (n≈1450)
  • Has concentration strength denominator value (n≈1450)
  • Has concentration strength numerator unit (n≈1450)
  • Has concentration strength numerator value (n≈1450)
  • Has manufactured dose form (n≈4850)
  • Has precise active ingredient (n≈5550)
  • Has presentation strength denominator unit (n≈4750)
  • Has presentation strength denominator value (n≈4750)
  • Has presentation strength numerator unit (n≈4750)
  • Has presentation strength numerator value (n≈4750)

Documentation Notification for Briefing Notes, Editorial Guidelines, and other documentation updates are posted on the project group website as they become available; see Drug Model Working Group - Directory for details

Briefing

Briefing note - Use of Additional Axiom Functionality and Remodeling Product Roles.pdf

Briefing note - Implications of describing liquid dose form product concepts using presentation strength.pdf

July 2018 International Edition
4

Summary of Substances Changes

Dietary subhierarchy. To remove context of use from the substance concepts and manage the situation where substances can be both a pharmaceutical ingredient and a foodstuff (n≈80) that had a tag of “- dietary” in the Fully Specified Name (FSN) and the Preferred Term (PT) were inactivated. Replacement concepts concept without "-dietary" in the FSN and PT were created. The top level concept "Dietary substance (substance)" has been inactivated and replaced with a new concept "Edible substance (substance)".

Radioactive isotope substances. These concepts have been remodelled and the terming normalised to provide consistent representation without the use of carats.

Cancer related substance. The subhierarchy has now been removed. Some concept have been inactivated. Some have been moved within the substances hierarchy.

Disposition Groupers

  • Existing Disposition groupers for substances have been remodeled and are now Fully Defined in the July 2018 data.
  • Additional Disposition Groupers for substances have been created (n≈50).
  • A new substance top level concept of “Substance categorized by disposition (substance)” has been created to allow substances with dispositions to be modeled as proximal primitive.

Structural Groupers 

  • Existing structural groupers have been retained as primitive substance concepts.
  • Additional Structural Groupers for substances have been created. (n≈20).
  • Chemical element groupers Inactivated and recreated to avoid the use of AND/OR and provide consistent modeling.

Combined Groupers (Structure + Disposition)

  • Existing concepts be have been remodeled as Fully Defined concepts in the July 2018 data

Role Groupers

  • Concepts that are Role grouper substances have been inactivated and others replaced (n≈100).This work is ongoing and further inactivations will be made in future releases. The retention of some role based groupers in the substances hierarchy means that some substances are not currently classifying correctly.

The "Is modification" of attribute has been implemented (n≈1200) resulting in flattening of the substances hierarchy.

Overall 447 new concepts added to the substances hierarchy. Just over 460 substance concepts have been inactivated in the July 2018 SNOMED CT release.

Documentation Notification for Briefing Notes, Editorial Guidelines, and other documentation updates are posted on the project group website as they become available; see Project Status Substance Hierarchy for details.

July 2018 International Edition
5

Internal QA - Situation and Findings

Test and procedure status: Inactivated 143 concepts in the Situations and Findings hierarchies with pattern "Test/procedure OFFERED" and "Test/procedure NOT OFFERED" as these represent an administrative status.

July 2018 International Edition
6

Internal QA - Qualifier Value

Inactivation of Agencies and organizations (qualifier value) and subtypes: moved to UK extension i.e. 66 concepts inactivated.

July 2018 International Edition
7

Replacement of OWL conversion script with a link to the open source directory

In January 2017 the original OWL conversion script (a.k.a. the "Spackman OWL script") was removed from the International Edition package, and has since been published as a separate artefact alongside each Release. 

Because this script does not recognize the two new OWL refsets (see section 3.3.2 of these Release Notes), the Terminology Release Advisory Group has determined that the script should no longer be distributed.

Going forward, Release Notes will now include a link to the new open source OWL conversion toolkit that can be found in the following repository (including documentation on its use):

https://github.com/IHTSDO/snomed-owl-toolkit

Please contact SNOMED International at support@snomed.org if you would like to provide any feedback on ways to extend and improve the new toolkit.

July 2018 International Edition
8

Deprecation of the Technical Guide Exemplars document from the International Edition release package

The Terminology Release Advisory Group has confirmed that there should be no impact from removing this almost entirely static document from the International Edition release package, and hosting it instead in a Confluence Page. From the July 2018 International release then, we will deprecate this file (doc_Icd10MapTechnicalGuideExemplars_[date].xlsx) from the Release package, and instead provide a link in the Release Notes to the new Confluence Page. Please see section 2.4.1.3 of the Release Notes for the relevant link.

July 2018 International Edition
9

Replacement of OWL conversion script with a link to the open source directory

In January 2017 the original OWL conversion script (a.k.a. the "Spackman OWL script") was removed from the International Edition package, and has since been published as a separate artefact alongside each Release. Because this script does not recognize the two new OWL refsets (see Item 7 above), the Terminology Release Advisory Group has determined that the script should no longer be distributed.

Going forward, Release Notes will now include a link to the new open source OWL conversion toolkit that can be found in the following repository (including documentation on its use):

https://github.com/IHTSDO/snomed-owl-toolkit

Please contact SNOMED International at support@snomed.org if you would like to provide any feedback on ways to extend and improve the new toolkit.

July 2018 International Edition
January 2018 International Edition
4

Summary of Drug Changes The following describes some of the deliverables scheduled for the January 2018 that continue to contribute to the delivery of this Strategy:

NOTE: Numbers are still evolving and will likely change before the final version of the release notes are generated.

New hierarchies

  • Basic dose form (basic dose form): New concepts created (n ≈ 150)
  • Dose form administration method (administration method): New concepts created (n ≈ 10)
  • Dose form intended site (intended site): New concepts created (n ≈ 25)
  • Dose form release characteristic (release characteristic): New concepts created (n ≈ 10)
  • Dose form transformation (transformation): New concepts created (n ≈ 5)
  • Pharmaceutical dose form (dose form):
    • New concepts created (n ≈ TBD)
    • Concepts remodeled (n ≈ TBD)
  • State of matter (state of matter): New concepts created (n ≈ 5)

New semantic tags 

  • (administration method)
  • (basic dose form)
  • (dose form)
  • (intended site)
  • (release characteristic)
  • (state of matter)
  • (transformation)

New attribute types

  • Has basic dose form
  • Has concentration strength denominator unit
  • Has concentration strength denominator value
  • Has concentration strength numerator unit
  • Has concentration strength numerator value
  • Has dose form administration method
  • Has dose form intended site
  • Has dose form release characteristic
  • Has dose form transformation
  • Has state of matter

Attribute type changes (for existing attributes) None

Grouper None

Medicinal product (MP) Updated ≈ 1100 existing concepts in accordance with new modeling and/or terming guidelines

  • Existing concept IDs, stated parents and definition status were retained
  • Missing |Has active ingredient| attributes were added; errors in existing content were corrected as they were identified

Medicinal product form (MPF) Negligible number of changes

Clinical drug (CD) Updated ≈ 3000 existing concepts changing terming from "Product containing X" to "Product containing only X"

Note that the terming for these concepts was updated in the 2017-July release to reflect "Product containing X"; upon advice from the Working Group, we elected to notify the Member Forum, Project Group, and Working Group of the retraction/substitution rather than inactivate/replace these concepts

New or updated concepts to support future simple map refset development    

For SNOMED CT to EDQM simple map refset:

  • 741068007|SNOMED CT to European Directorate for the Quality of Medicines & HealthCare simple map reference set module (core metadata concept)
  • 735233007|European Directorate for the Quality of Medicines & HealthCare simple map reference set (foundation metadata concept)

For SNOMED CT to UCUM simple map refset:

  • 741814003|SNOMED CT to Unified Code for Units of Measure simple map reference set module (core metadata concept)
  • 733900009|Unified Code for Units of Measure simple map reference set (foundation metadata concept)

Documentation created or updated including:

  • Position Statement
  • Briefing Paper re: update terming for Clinical Drug concepts changing "Product containing X" to "Product containing only X"
  • Editorial Guidelines for Modeling and Terming for Dose Form related hierarchies, including identification of |Pharmaceutical dose form| concepts to be used for modeling concepts in the International Release moving forward
  • Editorial Guidelines for Modeling and Terming for Product hierarchy

General content maintenance including:

  • Inactivation of concepts that are missing strength denominator (incomplete)
  • Inactivation of concepts that refer to color (out of scope)
  • Inactivation of concepts containing caplet (out of scope)
  • Inactivation of concepts containing "controlled-release" (ambiguous)
TBC (ongoing)
5Summary of Substances Changes

New hierarchies: Disposition (disposition)

New semantic tags (disposition)

New attribute types Has disposition

Is modification of

Attribute type changes Populated |Has disposition| grouper (n ≈ 150)

Groupers Updated modeling, definition status, and terming for groupers representing disposition (n ≈ 150) with associated change in stated parents for existing descendants (n ≈ 9000)

Briefing papers:

Documentation created or updated including:

  • Editorial Guidelines for Modeling and Terming for Substance hierarchy
  • Editorial Guidelines for Modeling and Terming for Disposition concepts

General content maintenance including:

  • Addition of X concepts as a result of gap analysis to identify missing concepts representing hydrates.
  • Addition of X concepts to represent substances as a result of content requests, new drug approvals, or gaps identified internally.
where X will be updated in the next week or so.